BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38754906)

  • 1. Scoping review of exposure questionnaires and surveys in interstitial lung disease.
    Barnes H; Elmrayed S; Barber CM; Feary J; Lee CT; Gandhi S; Peters CE; Salisbury ML; Johannson KA
    BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38754906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Remediation of Environmental Exposures in Patients With Interstitial Lung Disease: Evidence Review and Practical Considerations.
    Copeland CR; Collins BF; Salisbury ML
    Chest; 2021 Jul; 160(1):219-230. PubMed ID: 33609518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease.
    Dodia N; Amariei D; Kenaa B; Corwin D; Chelala L; Britt EJ; Sachdeva A; Luzina IG; Hasday JD; Shah NG; Atamas SP; Franks TJ; Burke AP; Hines SE; Galvin JR; Todd NW
    Respir Med; 2021 Apr; 179():106333. PubMed ID: 33676119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of a standardized chronic hypersensitivity pneumonitis exposure questionnaire.
    Barnes H; Chambers D; Grainge C; Corte TJ; Bastiampillai S; Frenkel S; Westall G; Collard H; Glaspole I
    Respirology; 2023 Apr; 28(4):366-372. PubMed ID: 36336654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occupational interstitial lung diseases.
    Spagnolo P; Ryerson CJ; Guler S; Feary J; Churg A; Fontenot AP; Piciucchi S; Udwadia Z; Corte TJ; Wuyts WA; Johannson KA; Cottin V
    J Intern Med; 2023 Dec; 294(6):798-815. PubMed ID: 37535448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Questionnaires or Serum Immunoglobulin G Testing in the Diagnosis of Hypersensitivity Pneumonitis among Patients with Interstitial Lung Disease.
    Jenkins AR; Chua A; Chami H; Diaz-Mendoza J; Duggal A; Knight S; Patolia S; Tamae-Kakazu M; Raghu G; Wilson KC
    Ann Am Thorac Soc; 2021 Jan; 18(1):130-147. PubMed ID: 32780584
    [No Abstract]   [Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of Existing Questionnaires for Identifying the Causes of Interstitial and Rare Lung Diseases.
    Polke M; Kirsten D; Teucher B; Kahn N; Geissler K; Costabel U; Herth FJF; Kreuter M
    Respiration; 2020; 99(2):119-124. PubMed ID: 32000164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental and occupational exposures in interstitial lung disease.
    Lee CT; Feary J; Johannson KA
    Curr Opin Pulm Med; 2022 Sep; 28(5):414-420. PubMed ID: 35838370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and Prevalence of Domestic and Occupational Inhalational Exposures Across Interstitial Lung Diseases.
    Lee CT; Adegunsoye A; Chung JH; Ventura IB; Jablonski R; Montner S; Vij R; Hines SE; Strek ME
    Chest; 2021 Jul; 160(1):209-218. PubMed ID: 33621598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the occupational disease consultant in the multidisciplinary discussion of interstitial lung diseases.
    Carlier S; Nasser M; Fort E; Lamouroux C; Si-Mohamed S; Chalabreysse L; Maury JM; Diesler R; Cottin V; Charbotel B
    Respir Res; 2022 Dec; 23(1):332. PubMed ID: 36482462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of physician history taking in complementing patient-reported interstitial lung disease questionnaire.
    Perluk TM; Friedman Regev I; Freund O; Kleinhendler E; Hershko T; Ben-Ami S; Bar-Shai A; Unterman A
    BMC Pulm Med; 2022 Dec; 22(1):489. PubMed ID: 36575434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.
    Fisher JH; Kolb M; Algamdi M; Morisset J; Johannson KA; Shapera S; Wilcox P; To T; Sadatsafavi M; Manganas H; Khalil N; Hambly N; Halayko AJ; Gershon AS; Fell CD; Cox G; Ryerson CJ
    BMC Pulm Med; 2019 Nov; 19(1):223. PubMed ID: 31771541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current perspective of progressive-fibrosing interstitial lung disease.
    Kishaba T
    Respir Investig; 2022 Jul; 60(4):503-509. PubMed ID: 35431170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial Lung Diseases in Developing Countries.
    Rivera-Ortega P; Molina-Molina M
    Ann Glob Health; 2019 Jan; 85(1):. PubMed ID: 30741505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms and management of cough in interstitial lung disease.
    Rasheed AZ; Metersky ML; Ghazal F
    Expert Rev Respir Med; 2023 Dec; 17(12):1177-1190. PubMed ID: 38159067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary rehabilitation for interstitial lung disease.
    Dowman L; Hill CJ; May A; Holland AE
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD006322. PubMed ID: 34559419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis.
    Lee CT; Strek ME; Adegunsoye A; Wong AW; Assayag D; Cox G; Fell CD; Fisher JH; Gershon AS; Halayko AJ; Hambly N; Khalil N; Kolb M; Lok SD; Manganas H; Marcoux V; Morisset J; Sadatsafavi M; Shapera S; To T; Wilcox P; Ryerson CJ; Johannson KA
    Respirology; 2022 Aug; 27(8):635-644. PubMed ID: 35512793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occupational Exposures and Subclinical Interstitial Lung Disease. The MESA (Multi-Ethnic Study of Atherosclerosis) Air and Lung Studies.
    Sack CS; Doney BC; Podolanczuk AJ; Hooper LG; Seixas NS; Hoffman EA; Kawut SM; Vedal S; Raghu G; Barr RG; Lederer DJ; Kaufman JD
    Am J Respir Crit Care Med; 2017 Oct; 196(8):1031-1039. PubMed ID: 28753039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial.
    Dowman LM; McDonald CF; Hill CJ; Lee AL; Barker K; Boote C; Glaspole I; Goh NSL; Southcott AM; Burge AT; Gillies R; Martin A; Holland AE
    Thorax; 2017 Jul; 72(7):610-619. PubMed ID: 28213592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.